Idorsia Pharmaceuticals is Biotechnology in Switzerland that focus on development compounds business. Founded in 2017. They cover business area such as Idorsia Ltd, drug, a biotech hub, Europe, development, small molecule, innovative therapeutic option, multiple therapeutic area, cardiovascular disorder, immunological disorder, orphan disease, a number, different disease, Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, Fabry disease, revenue, Switzerland.
2017
( 7 years old in 2024 )
Development Compounds
-
Hegenheimermattweg 91
4123 Allschwil
Switzerland
Private
Idorsia Ltddruga biotech hubEuropedevelopmentsmall moleculeinnovative therapeutic optionmultiple therapeutic areacardiovascular disorderimmunological disorderorphan diseasea numberdifferent diseaseResistant HypertensionlupusinsomniaCerebral vasospasmFabry diseaserevenueSwitzerland
* We use standard office opening hours in near Idorsia Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Idorsia Pharmaceuticals is Biotechnology business from Switzerland that founded in 2017 (7 years old in 2024), Idorsia Pharmaceuticals business is focusing on Development Compounds.
Idorsia Pharmaceuticals headquarter office and corporate office address is located in Hegenheimermattweg 91 4123 Allschwil Switzerland.
Idorsia Pharmaceuticals was founded in Switzerland.
In 2024, Idorsia Pharmaceuticals is currently focus on development compounds sector.
Above is snippet of Google Trends for "development compounds" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Idorsia Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
